E-Mail
IMAGE: Johns Hopkins Medicine researchers have shown that although two doses of a vaccine against SARS-CoV-2 the virus that causes COVID-19 confers some protection for people who have. view more
Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, with public domain images and background transplant surgery photograph courtesy of Johns Hopkins Medicine
Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 the virus that causes COVID 19 confers some protection for people who have received solid organ transplants, it s still not enough to enable them to dispense with masks, physical distancing and other safety measures.
Covid-19 Story Tip: Study Profiles Immune Cells Fighting COVID-19, May Help Guide Next-Gen Vaccine Development hopkinsmedicine.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hopkinsmedicine.org Daily Mail and Mail on Sunday newspapers.
Even as the first vaccines for SARS-CoV-2, the virus that causes COVID-19, are being distributed, scientists and clinicians around the world have remained steadfast in their efforts to better understand how the human immune system responds to the virus and protects people against it. Now, a research team led by Johns Hopkins Medicine and in collaboration with ImmunoScape, a U.S.-Singapore biotechnology company has published one of the most comprehensive characterizations to date of a critical contributor to that protection: the response of immune system cells called T lymphocytes (more commonly known as T cells) in people who have recovered from SARS-CoV-2 infection.